Residual cancer linked to worse long-term outcomes: Scientists
Researchers warn that residual microscopic cancer may persist post-radiotherapy, despite scans indicating tumor absence. This issue, highlighted by Dr. Muzamil Arshad and colleagues in Oncotarget, suggests treatment success reviews need rethinking. Residual disease is linked to higher recurrence and reduced survival across various cancers, stressing the importance of thorough follow-up assessments.